Symptom Antidote Solutions LLC is categorized under Unclassified in West Orange, NJ and active since 2008.
Symptom Antidote Solutions LLC was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Unclassified business, which does work in the B2B market, and is classified as a Unclassified, under code number 5416183 by the NAICS.
If you are seeking more information, feel free to contact Neil Manspeizer, Owner at the company’s single location by writing to 30 Edgemont Road, West Orange, New Jersey NJ 07052 or by phoning (973) 736-3420. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Symptom Antidote Solutions LLC |
| Contact Person: | Neil Manspeizer, Owner |
| Address: | 30 Edgemont Road, West Orange, New Jersey 07052 |
| Phone Number: | (973) 736-3420 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Unclassified |
| SIC Code: | 7389 |
| NAICS Code: | 5416183 |
| Share This Business: |
Symptom Antidote Solutions LLC was started in 2008 to provide professional Unclassified under the SIC code 7389 and NAICS code 5416183. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Neil Manspeizer, Owner for inquiries that concern Symptom Antidote Solutions LLC by calling the company number (973) 736-3420, as your correspondence is most welcome. Additionally, the physical location of the single location of Symptom Antidote Solutions LLC can be found at the coordinates 40.810463,-74.267507 as well as the street address 30 Edgemont Road in West Orange, New Jersey 07052.
For its online presence, you may visit Symptom Antidote Solutions LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.